对于重症监护中的贝叶斯剂量优化而言,万科米辛水平:一个前性队列研究
Natalia Dreyse1,2, Nicole Salazar2, Jose M Munita3
1Departamento de Paciente Crítico, Clínica Alemana de Santiago, Santiago, Chile.
Frontiers in medicine
|August 6, 2025
概括
在危急病患者中,只需两种万科米辛水平 (VLs),就能达到准确的万科米辛剂量. 这种使用贝叶斯软件的方法提供了更精确的度-时间曲线/最小抑制度 (AUC/MIC) 估计下的区域.
科学领域:
- 药理动力学和药理动力学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 在重症患者中优化万科米辛剂量对于有效治疗至关重要.
- 治疗药物监测,特别是度-时间曲线下面的区域/最小抑制度 (AUC/MIC) 的比率,是必不可少的.
- 准确估计AUC/MIC所需的万科米辛水平 (VLs) 的确切数量仍然不清楚.
研究的目的:
- 为了确定准确AUC/MIC估计所需的最小数量的万科米辛水平 (VLs).
- 评估不同范科米辛水平采样策略的准确性和偏差.
- 优化危急病患者群体中的万科米辛剂量方案.
主要方法:
- 一项前性队列研究,涉及36名严重病情严重的成年患者.
- 在峰值,贝塔和低谷阶段收集的万科米辛水平 (VLs).
- 使用PrecisePKTM贝叶斯软件推导出五种不同的AUC估计值,并将它们与通过梯形模型计算的参考AUC进行比较.
主要成果:
- 使用两种万科米辛水平 (高峰和低谷) 的AUC估计表明,与使用较少或仅使用先前数据的估计相比,其准确性更高,偏差更低.
- AUC-3 (高峰,低谷) 显示出明显更好的准确性 (p=0.042) 和较低的偏差 (p=0.036) 比AUC-4 (低谷) 和AUC-5 (仅在之前).
- 布兰德-阿尔特曼分析表明,AUC-3和AUC-2 (β,低谷) 与参考AUC之间的优异一致.
结论:
- 贝叶斯软件利用两种万科米辛水平 (VLs) 在重症患者中提供更准确,更不偏的AUC/MIC估计.
- 采用峰值和低谷米素水平的策略足以进行可靠的AUC/MIC估计.
- 这一发现可以简化在重症监护机构中对万科米辛的治疗药物监测.
相关概念视频
Renal Failure: Dose Adjustments
158
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
158
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
140
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
140
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
196
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
196
Pharmacokinetic Models: Comparison and Selection Criterion
149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K


